- Illustrations
- Specialized Illustrations
- Giardia Microscopic Structure
Giardia Microscopic Structure
White render of the Giardia protozoan's entire trophozoite structure, featuring a ventral sucking disc.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Giardia duodenalis is rendered as a complete trophozoite with its characteristic pear shaped body, broad and rounded anteriorly and tapering posteriorly. Paired nuclei sit in the anterior half, with median bodies and curved axonemal bundles tracking longitudinally toward the caudal end. Multiple flagella emerge from the ventral and posterior aspects, projecting distally beyond the body margin, while the ventral adhesive (sucking) disc occupies the ventral surface and faces inferiorly relative to the dorsal convexity. Bilateral symmetry is obvious. That matters. Morphologic identification of the trophozoite underpins routine parasitology, and this view foregrounds the ventral disc that allows attachment to duodenal and jejunal mucosa, a key mechanism behind malabsorption and steatorrhea in giardiasis. The paired nuclei and flagellar arrangement help distinguish Giardia from other intestinal protists on microscopy, and they align with the organism’s noninvasive pathophysiology, typically blunting microvilli rather than penetrating epithelium. For clinicians, this structure connects directly to exposure scenarios, classically contaminated surface water, daycare transmission, and post travel diarrhea. Use this asset in microbiology and parasitology teaching when contrasting trophozoite versus cyst forms, and in gastroenterology or infectious disease materials explaining why stool ova and parasite exams can miss infection when shedding is intermittent. It also fits lab manuals, board style review content, and patient education pieces that benefit from a clean white background and a clear 3D read of the ventral disc and flagella. Anatomical accuracy verified by SciePro's Medical Advisory Board.